THE WOODLANDS, Texas, Nov. 16 Recent federal legislation will have major impacts on cancer care. US Oncology, Inc., the cancer care organization dedicated to advancing cancer care in America and supporting the nations foremost cancer treatment and research network, announced today that it will host a complimentary educational webinar for community-based oncology practices to learn how this new legislation will impact cancer care in 2010. Hosted by Matt Brow, vice president of Government Relations and Public Policy for US Oncology, the webinar will be held at 2 p.m. EST (11 a.m. PST) on Friday, Nov. 20. To register, visit www.opspharmacist.com/opes. Registration is free, but space is limited.
Advertisement
Centers for Medicare and Medicaid (CMS) has issued its 2010 Medicare Physician Fee Schedule; the House of Representatives has passed its version of healthcare reform and coverage expansion legislation, and the Senate is expected to join the action in the coming weeks. "With the many changes in legislation that will directly impact cancer care physicians and patients across the country, it is imperative that practices understand these new developments and their implications to oncology," says Brow. "This interactive webinar will address questions about the new changes in government and help physicians better prepare their practices for 2010 and beyond."
Advertisement
The webinar will feature an overview of 2010 Medicare Physician Fee Schedule Final Rule, an update on Congressional health reform efforts, and implications for community oncology.
US Oncology offers free webinars designed to provide community-based oncology practices with information and education to help them successfully negotiate today's cancer care environment. The company is well aligned with more than 1,300 oncologists from across the nation and is active in all relevant healthcare initiatives and in pursuing legislation that supports the delivery of quality cancer care in the community. US Oncology is dedicated to providing the industry with timely and important information about current legislation changes that will impact its network and community-based oncology overall.
About US Oncology
US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,310 physicians operating in 493 locations, including 98 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.
SOURCE US Oncology, Inc.
